Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
Vincent Dupont, … , Ravi Thadhani, S. Ananth Karumanchi
Vincent Dupont, … , Ravi Thadhani, S. Ananth Karumanchi
Published August 9, 2022
Citation Information: J Clin Invest. 2022;132(20):e158346. https://doi.org/10.1172/JCI158346.
View: Text | PDF
Research Article Nephrology Reproductive biology

Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway

  • Text
  • PDF
Abstract

To understand how kidney donation leads to an increased risk of preeclampsia, we studied pregnant outbred mice with prior uninephrectomy and compared them with sham-operated littermates carrying both kidneys. During pregnancy, uninephrectomized (UNx) mice failed to achieve a physiological increase in the glomerular filtration rate and during late gestation developed hypertension, albuminuria, glomerular endothelial damage, and excess placental production of soluble fms–like tyrosine kinase 1 (sFLT1), an antiangiogenic protein implicated in the pathogenesis of preeclampsia. Maternal hypertension in UNx mice was associated with low plasma volumes, an increased rate of fetal resorption, impaired spiral artery remodeling, and placental ischemia. To evaluate potential mechanisms, we studied plasma metabolite changes using mass spectrometry and noted that l-kynurenine, a metabolite of l-tryptophan, was upregulated approximately 3-fold during pregnancy when compared with prepregnant concentrations in the same animals, consistent with prior reports suggesting a protective role for l-kynurenine in placental health. However, UNx mice failed to show upregulation of l-kynurenine during pregnancy; furthermore, when UNx mice were fed l-kynurenine in drinking water throughout pregnancy, their preeclampsia-like state was rescued, including a reversal of placental ischemia and normalization of sFLT1 levels. In aggregate, we provide a mechanistic basis for how impaired renal reserve and the resulting failure to upregulate l-kynurenine during pregnancy can lead to impaired placentation, placental hypoperfusion, an antiangiogenic state, and subsequent preeclampsia.

Authors

Vincent Dupont, Anders H. Berg, Michifumi Yamashita, Chengqun Huang, Ambart E. Covarrubias, Shafat Ali, Aleksandr Stotland, Jennifer E. Van Eyk, Belinda Jim, Ravi Thadhani, S. Ananth Karumanchi

×

Figure 3

PlGF rescues the preeclampsia-like phenotype in UNx mice.

Options: View larger image (or click on image) Download as PowerPoint
PlGF rescues the preeclampsia-like phenotype in UNx mice.
(A) Schematic ...
(A) Schematic representation of the experimental design. (B) MAP measurements in UNx mice treated with either PBS or recombinant PlGF in the NP state and during pregnancy. (C) Urine albumin/creatinine ratio in UNx mice treated with PBS or PlGF. (D) Plasma cystatin C measurements in UNx mice treated with PBS or PlGF. (E) The eGFR was calculated in UNx mice treated with PBS or PlGF as described in Methods. (F) Histopathological analysis of renal tissue at GD18 from 1 representative UNx mouse treated with PBS and 1 UNx mouse treated with PlGF. H&E-stained images (scale bars: 50 μm) and EM analysis (scale bars: 1 μm) show significant improvement in endothelial lesions in the PlGF-treated mouse (arrow shows preserved endothelial fenestration) compared with the PBS-treated mouse (arrows show enlarged ECs with segmental loss of fenestration). (G) The glomerular capillary area at GD18, quantified using ImageJ as described in Methods, was decreased in UNx mice treated with PlGF compared with those treated with PBS. Obstetrical outcomes for UNx mice treated with PBS or PlGF were assessed according to the number of fetuses (H), fetus (I) and placenta (J) weights, placenta/fetus weight ratio (K), and fetal resorption rate (L). (M) UARIs were calculated at GD14 and GD18 for UNx mice treated with PBS or PlGF as described in Methods. (N) Quantification of placental sFlt1 mRNA expression in UNx mice treated with PBS or PlGF at GD18. n = 4 per group. All data were normalized to 18s (ΔCt). Data are presented as the mean ± SD. n = 6 per group unless otherwise indicated. *P < 0.05 for UNx mice treated with PlGF versus those treated with PBS, by unpaired, 2-tailed Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts